Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Author(s) -
Alana F. Ogata,
ChiAn Cheng,
Michaël Desjardins,
Yasmeen Senussi,
Amy C Sherman,
Megan Powell,
Lewis A. Novack,
Salena S Von,
Xiaofang Li,
Lindsey R. Baden,
David R. Walt
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab465
Subject(s) - medicine , coronavirus , covid-19 , antibody , immunology , respiratory system , virology , immunoglobulin g , severe acute respiratory syndrome coronavirus , severe acute respiratory syndrome , antigen , infectious disease (medical specialty) , disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. Eleven of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day 1 after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of immunoglobulin G (IgG) and immunoglobulin A (IgA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom